Table 4.
Pretreatment CTC Count / mL | PSA ≤ 4 at 28 Weeks | PSA > 4 at 28 Weeks | p-value |
---|---|---|---|
<2 | 30 (83.3%) | 6 (16.7%) | 0.49 |
2+ | 7 (77.8%) | 2 (22.2%) | |
Pretreatment CTC Count / mL | PSA CR | PSA PR/SD | p-value |
<2 | 25 (69.4%) | 11 (30.6%) | 0.04 |
2+ | 3 (33.3%) | 6 (66.7%) |